ArticlePharmaceutics2023

pH-Responsive Hybrid Nanoassemblies for Cancer Treatment: Formulation Development, Optimization, and In Vitro Therapeutic Performance.

Patrícia V Teixeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.